<html><!-- #BeginTemplate "/Templates/news2003.dwt" -->
<head>
<!-- #BeginEditable "doctitle" --> 
<title>Public Citizen</title>
<!-- #EndEditable -->
<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1">
</head>

<body text="#000000" link="#0000FF" bgcolor="#000099" vlink="#0000FF" alink="#0000FF">
<div align="center">
<center>
<table width="600" bgcolor="#FFFFFF" cellpadding="0" cellspacing="0" align="center">
<tr align="center" valign="top">
<td>
<table border="0" width="100%" cellspacing="0" cellpadding="0" align="center">
<tr valign="middle">
<td align="center" width="15" height="100">&nbsp;</td>
<td align="center" width="340" height="100"> 
                <p align="left"><a href="http://www.commondreams.org"><img border="0" src="../images/newswire.gif" width="340" height="75" alt="Common Dreams NewsCenter" align="bottom"></a> 
              </td>
              <td align="center" width="245" height="100"><a href="http://www.commondreams.org/special/feature.htm"><img src="../special/images/feature.gif" width="230" height="75" border="0"></a></td>
</tr>
<tr valign="middle" align="left" bgcolor="#F4F4E1">
<td height="25" width="15">&nbsp;</td>
              <td bgcolor="#F4F4E1" height="25" width="340"> 
                <p align="left"><b><font face="Arial, Helvetica, sans-serif" size="1">&nbsp;<a href="http://www.commondreams.org/">Home</a> 
                  | <a href="http://www.commondreams.org/newswire.htm">Newswire</a> 
                  |&nbsp;<a href="http://www.commondreams.org/about.htm">About 
                  Us</a> | <a href="http://www.commondreams.org/donate.htm">Donate</a> 
                  </font></b><font size="1" face="Arial, Helvetica, sans-serif"><b> 
                  | <a href="http://www.commondreams.org/email.htm">Sign-Up</a> 
                  | <a href="http://www.commondreams.org/archives.htm">Archives</a></b></font><font color="#000000" size="1" face="Arial"> 
                  </font><font color="#000000" size="1" face="Arial"> </font> 
              </td>
<td align="center" bgcolor="#F4F4E1" height="25" width="245"><font face="Arial, Helvetica, sans-serif" size="1" color="#000099">
<script>
var mydate=new Date()
var theYear=mydate.getFullYear()
var day=mydate.getDay()
var month=mydate.getMonth()
var daym=mydate.getDate()
if (daym<10)
daym="0"+daym
var dayarray=new Array("Sunday","Monday","Tuesday","Wednesday","Thursday","Friday","Saturday")
var montharray=new Array("January","February","March","April","May","June","July","August","September","October","November","December")
document.write(dayarray[day]+", "+montharray[month]+" "+daym+", "+theYear)
</script>
</font></td>
</tr>
</table>
<table border="0" cellpadding="3" cellspacing="0" width="100%">
<tr bgcolor="#E8E8E8" align="right" valign="middle"> 
<td width="600" colspan="5" height="25"> 
     
<div align="right"><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b> 
<a href="http://www.commondreams.org/">Home</a> &gt; <a href="http://www.commondreams.org/community.htm">Progressive 
Community</a> &gt; <a href="http://www.commondreams.org/newswire.htm">NewsWire</a> 
</b></font><b><font face="Verdana, Arial, Helvetica, sans-serif" size="2">&gt; 
For Immediate Release&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></b></div>
</td>
</tr>
<tr> 
<td valign="top" align="left" bgcolor="#E8E8E8" width="15" rowspan="7"> <font face="Arial, Helvetica, sans-serif" size="2"><a href="http://www.commondreams.org/wirearchive.htm">
</a></font> 
<p align="left"><font face="Arial, Helvetica, sans-serif" size="2"><small>
</small></font></p>
<p align="left">&nbsp;</p>
<p>
</td>
<td valign="top" align="left" bgcolor="#FFFFFF" width="20" rowspan="7">&nbsp;</td>
<td valign="bottom" align="left" bgcolor="#FFFFFF" width="90%">
<div align="right"><!-- referralblast starts here -->
<a href="http://www.referralblast.com/cs/com/co1.asp" onclick="window.open('http://www.referralblast.com/cs/com/co1.asp?url=' + location.href,'comWnd','width=440,height=476,scrollbars=yes,menubar=no,resizable=yes'); return false;" target="_blank" onMouseOver="window.status='Send this page to a friend'; return true;" onMouseOut="window.status=''; return true;"><img src="../images/rn-spa-c.gif" alt="Send this page to a friend" width="118" height="23" border="0"></a> 
<!-- referralblast ends here -->
</div>
</td>
<td valign="top" align="left" bgcolor="#FFFFFF" width="20" rowspan="7">&nbsp;</td>
<td valign="top" align="left" bgcolor="#E8E8E8" width="15" rowspan="7">&nbsp; </td>
</tr>
<tr> 
<td valign="top" align="left" width="90%" bgcolor="#FFFFFF"><!-- #BeginEditable "Contact" --> 
                <div align="left"> 
                  <table width="100%" cellpadding="3">
                    <tr> 
                      <td align="left" valign="top" width="35%"><font size="2" face="Arial, Helvetica, sans-serif"><strong>FOR 
                        IMMEDIATE RELEASE<br>
                        </strong>MARCH 31, 2003<br>
                        1:53 PM<strong><br>
                        </strong></font></td>
                      <td align="left" valign="top" width="65%"><font size="2" face="Arial, Helvetica, sans-serif"><b>CONTACT: 
                        </b> <b><a href="http://www.citizen.org" target="_new">Public 
                        Citizen</a><br>
                        </b>202-588-7742</font><font size="2" face="Arial, Helvetica, sans-serif"><br>
                        </font> </td>
                    </tr>
                  </table>
                </div>
                <!-- #EndEditable --></td>
</tr>
<tr> 
<td valign="top" align="left" bgcolor="#FFFFFF" width="90%"></td>
</tr>
<tr> 
<td valign="top" align="left" bgcolor="#FFFFFF" width="90%"><font size="4" face="Arial, Helvetica, sans-serif"><b><!-- #BeginEditable "Header" -->
                <div align="center">New Report Confirms That Drug Review Process 
                  Doesn&#146;t Protect Consumers<br>
                  <font size="2">Many FDA Reviewers Say Approval Process Has Worsened; 
                  FDA Should Consider Lengthening Drug Approval Times, Inspector 
                  General&#146;s Report Says</font></div>
                <!-- #EndEditable --></b></font></td>
</tr>
<tr> 
<td valign="top" align="left" bgcolor="#FFFFFF" width="90%">&nbsp; 
</td>
</tr>
<tr> 
<td valign="top" align="left" bgcolor="#FFFFFF" width="90%"><!-- #BeginEditable "Body" --><font size="2" face="Arial, Helvetica, sans-serif">WASHINGTON 
                - March 31 - A new report from the U.S. Department of Health and 
                Human Services&#146; (HHS) Inspector General confirms that the 
                federal government&#146;s current drug review process does not 
                adequately protect consumers from harmful prescription medications, 
                Public Citizen said today. Seven drugs approved since 1996, including 
                Rezulin and Redux (used to treat diabetes and obesity) have been 
                removed from the market because they were deemed unsafe.</font> 
                <p><font face="Arial, Helvetica, sans-serif" size="2"> According 
                  to the report, 40 percent of U.S. Food and Drug Administration 
                  (FDA) long-term reviewers responding to a survey conducted by 
                  the Inspector General said that the review process has worsened 
                  since they were first employed at the agency. The report recommends 
                  that in most circumstances, the permitted review period for 
                  new drugs, which ranges between six and 12 months, be extended 
                  by one to two months.</font></p>
                <p><font face="Arial, Helvetica, sans-serif" size="2">All new 
                  drugs must be reviewed for safety and efficacy before being 
                  put on the market. Under legislation that took effect in 1992, 
                  drug companies pay &quot;user fees,&quot; essentially paying 
                  the salaries of the people reviewing the drugs.</font></p>
                <p><font face="Arial, Helvetica, sans-serif" size="2">&quot;The 
                  FDA is supposed to rigorously screen all new drugs and ensure 
                  that they are safe and effective before they are sold to millions 
                  of people,&quot; said Peter Lurie, M.D., MPH, deputy director 
                  of Public Citizen&#146;s Health Research Group. &quot;Unless 
                  the agency gets out of the snug bed it is currently sharing 
                  with industry, unsafe drugs will continue to slip through the 
                  safety net.&quot;</font></p>
                <p><font face="Arial, Helvetica, sans-serif" size="2">The centerpiece 
                  of the Inspector General&#146;s report is a survey of 401 new 
                  drug reviewers in the FDA&#146;s Center for Drug Evaluation 
                  and Research. Fifty-eight percent said that the six months allotted 
                  for review of priority New Drug Applications was inadequate; 
                  25 percent felt similarly about the target of 10 months provided 
                  for review of most standard applications. A priority drug is 
                  a breakthrough drug or one designed to treat an unusual condition; 
                  a minority of drugs fall into this category.</font></p>
                <p><font face="Arial, Helvetica, sans-serif" size="2">Eighteen 
                  percent of these physicians and scientists felt pressure to 
                  recommend that drugs be approved for sale despite their reservations 
                  about the drug&#146;s safety, efficacy or quality. (The report 
                  does not say who exerted the pressure.) The report concludes: 
                  &quot;Overall, these findings present a significant warning 
                  signal.&quot;</font></p>
                <p><font face="Arial, Helvetica, sans-serif" size="2">These findings 
                  are consistent with prior research conducted by Public Citizen 
                  and the FDA itself. In December 1998, Public Citizen conducted 
                  a study (<a href="http://www.citizen.org/publications/release.cfm?ID=7104" target="_new">click 
                  here to view</a>) showing that 19 FDA medical officers identified 
                  27 new drugs that they had reviewed in the past three years 
                  that they thought should not be approved but the agency approved 
                  anyway. Seventeen medical officers described the current standards 
                  of FDA review for safety and efficacy as &quot;lower&quot; or 
                  &quot;much lower&quot; compared to those in existence prior 
                  to 1995. And several medical officers said they had been instructed 
                  by their superiors to censor their reports or presentations.</font></p>
                <p><font face="Arial, Helvetica, sans-serif" size="2">A subsequent 
                  FDA survey in 2001 precipitated by high turnover rates among 
                  employees in the agency showed that about one-third of medical 
                  officers did not feel comfortable expressing differing scientific 
                  opinions, and a similar number felt that decisions adverse to 
                  a drug were stigmatized within the agency. A number of reviewers 
                  said that decisions should be based more on science and less 
                  on corporate wishes.</font></p>
                <p><font face="Arial, Helvetica, sans-serif" size="2">This anti-scientific 
                  climate was confirmed in the new Inspector General&#146;s report. 
                  Twenty-one percent of those polled indicated that the work environment 
                  at the FDA allowed for scientific disagreement to only a small 
                  or no extent. The report also indicates that, over time, a lower 
                  percentage of drugs, particularly priority drugs, is being presented 
                  to the FDA&#146;s external advisory committees, reflecting the 
                  speed-up at the FDA and minimizing the opportunity for valuable 
                  external peer review.</font></p>
                <p><font face="Arial, Helvetica, sans-serif" size="2">&quot;FDA&#146;s 
                  reliance on user fees from the industry has skewed the drug 
                  approval process toward the industry&#146;s financial interests 
                  and away from consumer protection,&quot; Lurie said. &quot;Only 
                  a purely government-funded agency, as the FDA had been from 
                  its origins in 1906 to 1992, can have the independence necessary 
                  to keep unsafe and/or ineffective drugs off the market.&quot;</font></p>
                <p><font face="Arial, Helvetica, sans-serif" size="2"><a href="http://www.oig.hhs.gov/oei/reports/oei-01-01-00590.pdf" target="_new">Click 
                  here to view the report</a>, FDA&#146;s Review Process for New 
                  Drug Applications: A Management Review (OEI-01-01-00590).</font></p>
                <p></p>
                <p></p>
                <font size="2" face="Arial, Helvetica, sans-serif">
                <p align="center"><font face="Arial, Helvetica, sans-serif" size="2">###</font></p>
                </font><!-- #EndEditable --></td>
</tr>
<tr> 
              <td valign="top" align="left" bgcolor="#FFFFFF" width="90%">
<!-- referralblast starts here -->
<a href="http://www.referralblast.com/cs/com/co1.asp" onclick="window.open('http://www.referralblast.com/cs/com/co1.asp?url=' + location.href,'comWnd','width=440,height=476,scrollbars=yes,menubar=no,resizable=yes'); return false;" target="_blank" onMouseOver="window.status='Send this page to a friend'; return true;" onMouseOut="window.status=''; return true;"><img src="../images/rn-spa-c.gif" alt="Send this page to a friend" width="118" height="23" border="0"></a> 
<!-- referralblast ends here -->
</td>
</tr>
<tr bgcolor="#E8E8E8"> 
<td valign="top" align="center" width="100%" colspan="5" height="15">

<div align="center"><small><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Common Dreams <a href="http://www.commondreams.org/">NewsCenter</a>&nbsp;is a non-profit news service<br>
 providing breaking news and views for the Progressive Community.</b></font></small> 
</div>
<p align="center"><font face="Verdana, Arial, Helvetica, sans-serif" size="1"><small>The 
press release posted here has been provided to Common Dreams NewsWire by  
one of the many progressive organizations who make up <a href="http://www.commondreams.org/community.htm">America's Progressive Community</a>. 
If 
you wish to comment on this press release or would like more information, 
please contact the organization  directly.<br>
 
</small></font><font size="1" face="Arial">*all times Eastern US (GMT-5:00)</font><font face="Arial, Helvetica, sans-serif" size="2"><small>
</small></font><font face="Arial, Helvetica, sans-serif" size="2"><small><br>
 <br>
</small><b><font size="4">Making News?</font></b><br>
                  Read our <a href="http://www.commondreams.org/newspolicy.htm">Guidelines 
                  for Submitting News Releases</a><br>
                  </font></p>
<div align="center">
<center>
                    <font face="Arial, Helvetica, sans-serif" size="3"><b><font face="Arial, Helvetica, sans-serif" size="1"><a href="http://www.commondreams.org/">Home</a> 
                    | <a href="http://www.commondreams.org/newswire.htm">Newswire</a> 
                    |&nbsp;<a href="http://www.commondreams.org/about.htm">About 
                    Us</a> | <a href="http://www.commondreams.org/donate.htm">Donate</a> 
                    </font></b><font size="1" face="Arial, Helvetica, sans-serif"><b> 
                    | <a href="http://www.commondreams.org/email.htm">Sign-Up</a> 
                    | <a href="http://www.commondreams.org/archives.htm">Archives</a></b></font><font color="#000000" size="1" face="Arial"> 
                    </font><font size="1" face="Arial, Helvetica, sans-serif"><b> 
                    </b></font></font><b><font face="Arial, Helvetica, sans-serif" size="2"><br>
</font></b>
</center>
</div>
<p>
<div align="center"><font face="Arial, Helvetica, sans-serif" size="2"><i>Tell Us What You Think:</i> 
 <a href="mailto:editor@commondreams.org">editor@commondreams.org 
</a><br>
 
</font> 
 


</div>
                <p align="center"> <font face="Arial, Helvetica, sans-serif" size="1">© Copyright 
                  1997-2003 Common Dreams.<br>
 www.commondreams.org</font></p>
                <p>
              </td>
</tr>
</table>
</td>
</tr>
</table>

</center>
</div>
<p align="center">&nbsp;</p>
</body>

<!-- #EndTemplate --></html>
